These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 8569618)
1. TSH-receptors and prognostic value of their analysis. Durica S; Zakula Z; Isenović E; Ratković M; Ribarac-Stepić N Med Pregl; 1993; 46 Suppl 1():82-4. PubMed ID: 8569618 [TBL] [Abstract][Full Text] [Related]
2. Serum thyroglobulin level and thyrotropin receptors in plasma membranes from thyroid nodular relapse. Djurica S; Zakula Z; Isenović E; Djodjević D; Ribarac-Stepić N Endocr Regul; 1993 Mar; 27(1):35-40. PubMed ID: 8003707 [TBL] [Abstract][Full Text] [Related]
3. Thyroid functional status and TSH receptors of cold nodular tissue. Djurica S; Misković D; Ratković M; Ribarac-Stepić N Endocrinol Exp; 1989 Dec; 23(4):279-86. PubMed ID: 2620659 [TBL] [Abstract][Full Text] [Related]
4. Thyrotropin receptors, thyroid hormones and thyroglobulin in patients with Hashimoto's thyroiditis. Djurica S; Zakula Z; Isenović E; Ratković M; Ribarac-Stepić N Endocrinol Exp; 1990 Sep; 24(3):357-67. PubMed ID: 2226281 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO). Giovanella L; Ceriani L; Garancini S Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370 [TBL] [Abstract][Full Text] [Related]
6. Interrelationship between thyroid nodularity and TSH level. Sachmechi I; Vahedi M; Nalamasu S; Vuppalanchi R Mt Sinai J Med; 2005 Jan; 72(1):33-5. PubMed ID: 15682260 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of dynamic contrast medium enhanced magnetic resonance imaging in preoperative detection of thyroid carcinoma. Tezelman S; Giles Y; Tunca F; Gok K; Poyanli A; Salmaslioglu A; Terzioglu T Arch Surg; 2007 Nov; 142(11):1036-41. PubMed ID: 18025330 [TBL] [Abstract][Full Text] [Related]
8. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter]. Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791 [TBL] [Abstract][Full Text] [Related]
9. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease. De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104 [TBL] [Abstract][Full Text] [Related]
10. Evaluation and management of multinodular goiter. Hurley DL; Gharib H Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728 [TBL] [Abstract][Full Text] [Related]
11. High rate of recurrence after lobectomy for solitary thyroid nodule. Marchesi M; Biffoni M; Faloci C; Biancari F; Campana FP Eur J Surg; 2002; 168(7):397-400. PubMed ID: 12463429 [TBL] [Abstract][Full Text] [Related]
12. [Repeated surgeries on the thyroid gland in nodular euthyroid goiter]. Vetshev PS; Chilingaridi KE; Bannyĭ DA; Dmitriev EE Khirurgiia (Mosk); 2004; (8):37-40. PubMed ID: 15340316 [TBL] [Abstract][Full Text] [Related]
13. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases]. Rink T; Dembowski W; Schroth HJ; Klinger K Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter. Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787 [TBL] [Abstract][Full Text] [Related]
15. Cytologic distinction of goiterous nodules from morphologically normal thyroid: analyses of cytomorphologic features. Layfield LJ; Wax T; Jones C Cancer; 2003 Aug; 99(4):217-22. PubMed ID: 12925983 [TBL] [Abstract][Full Text] [Related]
16. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886 [TBL] [Abstract][Full Text] [Related]
17. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone. Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259 [TBL] [Abstract][Full Text] [Related]
18. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease. Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276 [TBL] [Abstract][Full Text] [Related]
19. [Recurrences after thyroid lobectomy for benign thyroid diseases: analysis of a clinical-instrumental follow up]. Marchesi M; Nuccio G; Faloci C; De Cristofaro F Ann Ital Chir; 1998; 69(5):581-6. PubMed ID: 10052208 [TBL] [Abstract][Full Text] [Related]
20. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]